Screening specimens for vancomycin-resistant enterococcus

Laboratory Medicine

Volumn 27, Issue 1, 1996, Pages 53-55

  Jensen, Bette J ^a  

^a ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CULTURE MEDIUM; ENTEROCOCCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; ISOLATION PROCEDURE; PHENOTYPE; SCREENING TEST; TRANSPOSON;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; NEGIBACTERIA;

EID: 0030039494     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1093/labmed/27.1.53     Document Type: Article

References (26)

1. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol. 1995;33:24-27.
2. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria: a report on the Rockefeller University workshop. N Engl J Med. 1994;330:1247-1251.
3. Al-Obeid S, Gutmann L, Shlaes DM, Williamson R, Collatz E. Comparison of vancomycin-inducible proteins from four strains of enterococci. FEMS Microbiol Lett. 1990;70:101-106.
4. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother. 1993;37:1563-1571.
5. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev. 1990;3:46-65.
6. Facklam RR, Collins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27:731-734.
7. Vincent S, Knight RG, Green M, Sahm DF, Shlaes DM. Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol. 1991;29:2335-2337.
8. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol. 1995;16:105-113.
9. Edberg SC, Hardalo CJ, Kontnick C, Campbell S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol. 1994;32:2182-2184.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. 5th ed. Approved standard M2-A5. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
11. Edberg SC, Trepeta RW, Kontnick CM, Torre AR. Measurement of active constitutive β-D-glucosidase (esculinase) in the presence of sodium desoxycholate. J Clin Microbiol. 1985;21:363-365.
12. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 3rd ed. Approved standard M7-A3. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993.
13. Johnson AP, Uttley AHC, Woodford N, George RC. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990;3:280-291.
14. Uttley AHC, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect. 1989;103:173-181.
15. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother. 1993;37:2311-2317.
16. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993;16:750-755.
17. Montecalvo M, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother. 1994;38:1363-1367.
18. Fantin B, Leclercq R, Arthur M, Duval J, Carbon C. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Antimicrob Agents Chemother. 1991;35:1570-1575.
19. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet. 1993;342:76-79.
20. Karenfil LV, Murphy M, Josephson A, Gaynes R, Mandel L, Hill BC. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol. 1992;13:195-200.
21. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992;117:112-116.
22. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hasp Epidemiol. 1992;13:700-705.
23. Shlaes DM. Vancomycin-resistant bacteria. Infect Control Hosp Epidemiol. 1992;13:193-194.
24. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology; 1995:308-313.
25. Swenson JM, Ferraro MJ, Sahm DF, Charache P, Tenover FC. New vancomycin disk diffusion breakpoints for enterococci. J Clin Microbiol. 1992;30:2525-2528.
26. Tenover FC, Swenson JM, O'Hara CM, Stocker SA. Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 1995;33:1524-1527.